UNCLASSIFIED |
This Threat Assessment is a national-level strategic assessment of methamphetamine trafficking in the United States. It addresses significant trends in methamphetamine production, transportation, distribution, and abuse. It discusses a wide range of issues, including methamphetamine production in Mexico, the increasing availability of Mexican ice methamphetamine in domestic drug markets, and apparent methamphetamine shortages in some western markets.
Your questions, comments, and suggestions for future subjects are welcome at any time. Addresses are provided at the end of the page.
Main cover photo:
DEA - Ice methamphetamine
Inset photos from top:
Snohomish (Washington) Regional Task Force -
Methamphetamine clandestine laboratory precursor chemicals
Grand Forks (North Dakota) Narcotics Task Force
- One-bucket meth lab seizure
DEA - Ice methamphetamine crystals with pipe
Snohomish (Washington) Regional Drug Task Force
- Methamphetamine clandestine laboratory components and precursor chemicals
Organized Crime Drug Enforcement Task Force
Region Methamphetamine Summaries
Florida/Caribbean OCDETF
Region
Great Lakes OCDETF Region
Mid-Atlantic OCDETF Region
New England OCDETF Region
New York/New Jersey OCDETF
Region
Pacific OCDETF Region
Southeast OCDETF Region
Southwest OCDETF Region
West Central OCDETF Region
Appendix A. Map
Appendix B. Tables
Appendix C. Methamphetamine Prices
Chart 1. Commercial Pseudoephedrine Imports
to Mexico, in Metric Tons, 2004-2006
Chart 2. Methamphetamine Seizures on the
Southwest Border, in Kilograms, 2001-2007
Chart 3. Number of Reported Methamphetamine
Laboratory Seizures, 2002-2007
Chart 4. Greatest Drug Threat: Percentage of State
and Local Agencies Reporting
Chart 5. Number of Primary Methamphetamine
Treatment Admissions to Publicly Funded Treatment Facilities, 2000-2005
Figure 1. The nine OCDETF regions.
Figure 2. The Florida/Caribbean Region.
Figure 3. The Great Lakes Region.
Figure 4. The Mid-Atlantic Region.
Figure 5. The New England Region.
Figure 6. The New York/New Jersey Region.
Figure 7. The Pacific Region.
Figure 8. The Southeast Region.
Figure 9. The Southwest Region.
Figure 10. The West Central Region.
Table 1. Wholesale-Level Ice Methamphetamine
Prices, U.S. Dollars per Pound, Reported to NDIC in December 2006 and June 2007;
Markets Experiencing Significant Price Increases
Table 2. Top 5 States for Identity Theft
Complaints per 100,000 Population, 2006
Map 1. National Drug Threat Survey 2007 greatest drug threat by OCDETF region.
Table 1. Trends in Percentage of Past Year
Methamphetamine Use, 2002-2006
Table 2. Amphetamine (including
Methamphetamine) Treatment Admissions by OCDETF Region, 2001-2005
Table 3. Federal-Wide U.S. Methamphetamine
Seizures, in Kilograms, 2002-2006
Table 4. Number of Federal
Methamphetamine-Related Arrests, United States, 2002-2006
Table 5. Average Purity of Methamphetamine
Samples Tested, by Percentage, 2002-2006
Table 1. Methamphetamine Prices by State and City--January Through June 2007
The National Methamphetamine Threat Assessment 2008 is a national-level strategic assessment of methamphetamine trafficking in the United States. This assessment addresses significant trends in methamphetamine production, transportation, distribution, and abuse. It discusses a wide range of issues, including methamphetamine production in Mexico, the increasing availability of Mexican ice methamphetamine in domestic drug markets, and apparent methamphetamine shortages in some western markets. This assessment draws upon the National Drug Threat Assessment 2008, regional drug intelligence products prepared by the National Drug Intelligence Center, and reporting from numerous federal, state, and local law enforcement agencies.
Methamphetamine production and distribution are undergoing significant changes. Methamphetamine use has stabilized nationally since 2002 after increasing during much of the 1990s, and domestic production of methamphetamine has decreased dramatically since 2004. However, the increasing prevalence of high-purity ice methamphetamine throughout the country and the expansion of methamphetamine networks operated by Mexican and, more recently, Asian drug trafficking organizations (DTOs) have largely sustained methamphetamine markets in the United States. Despite heightened chemical import restrictions in Mexico, methamphetamine production in that country has increased since 2004, and Mexico is now the primary source of methamphetamine to U.S. drug markets. Moreover, large-scale methamphetamine production is increasing in Canada as outlaw motorcycle gangs (OMGs) and Asian DTOs expand their methamphetamine operations. Some methamphetamine produced in Canada is distributed in U.S. drug markets, including methamphetamine tablets sold as MDMA (3,4-methylenedioxymethamphetamine, also known as ecstasy). Nevertheless, Mexican DTOs distributing Mexican methamphetamine continue to dominate domestic markets. In fact, distribution of the drug in domestic drug markets by Mexican DTOs is increasing, supplanting many local dealers who had previously produced and distributed the drug independently.
National Drug Intelligence Center
319 Washington Street, 5th Floor
Johnstown, PA 15901-1622
Tel. (814) 532-4601
FAX (814) 532-4690
E-mail NDIC.Contacts@usdoj.gov
National Drug Intelligence Center
United States Department of Justice
Robert F. Kennedy Building (Room 1335)
950 Pennsylvania Avenue NW
Washington, DC 20530
Tel. (202) 432-4040
FAX (202) 514-4252
ADNET: http://ndicosa
DOJ: http://www.usdoj.gov/ndic/
LEO: https://cgate.leo.gov/http/leowcs.leopriv.gov/lesig/ndic/index.htm
RISS: ndic.riss.net
To Top To Contents To Next Page
To Publications Page To Home Page
UNCLASSIFIED
End of page.